CeriBell Inc. (CBLL)
NASDAQ: CBLL
· Real-Time Price · USD
16.95
-0.23 (-1.34%)
At close: Jun 03, 2025, 3:59 PM
16.93
-0.12%
After-hours: Jun 03, 2025, 04:20 PM EDT
Company Description
CeriBell, Inc. develops AI based point-of-care electroencephalography (EEG) technology for the detection and treatment of neurological conditions.
The company develops Ceribell System, a novel, point-of-care EEG platform to address the unmet needs of patients in the acute care setting.
It also offers EEG disposable headbands; and pocket-sized battery-operated recorders.
The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015.
The company was incorporated in 2014 and is based in Sunnyvale, California.
CeriBell Inc.
| Country | United States |
| IPO Date | n/a |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 281 |
| CEO | Dr. Xingjuan Chao Ph.D. |
Contact Details
Address: 360 North Pastoria Avenue Sunnyvale, California United States | |
| Website | https://ceribell.com |
Stock Details
| Ticker Symbol | CBLL |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001861107 |
| CUSIP Number | n/a |
| ISIN Number | US15678C1027 |
| Employer ID | 47-1785452 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Dr. Xingjuan Chao Ph.D. | Co-Founder, President, Chief Executive Officer & Director |
| Dr. Raymond Woo Ph.D. | Chief Technology Officer |
| Kristie Rodenbush | Chief People Officer |
| Scott Blumberg | Chief Financial Officer |
| Baharan Kamousi Ph.D. | Senior Vice President of Data Science |
| Brian P. Price | Senior Vice President of Marketing |
| Dan Rogy | Senior Vice President of Operations |
| Dr. Josef Parvizi M.D., Ph.D. | Co-Founder, Chief Medical Advisor & Director |
| Louisa Daniels J.D., M.B.A. | General Counsel |
| Sean Manni | Senior Vice President of Sales |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 19, 2025 | 4 | Filing |
| May 08, 2025 | 10-Q | Quarterly Report |
| May 08, 2025 | 8-K | Current Report |
| May 02, 2025 | SCHEDULE 13G | Filing |
| Apr 30, 2025 | ARS | Filing |
| Apr 30, 2025 | DEFA14A | Filing |
| Apr 30, 2025 | DEF 14A | Filing |
| Apr 24, 2025 | 4 | Filing |
| Apr 21, 2025 | 4 | Filing |
| Apr 11, 2025 | 8-K | Current Report |